Related references
Note: Only part of the references are listed.Mechanisms of tau-induced neurodegeneration
Khalid Iqbal et al.
ACTA NEUROPATHOLOGICA (2009)
Diagnostic value of CSF biomarker profile in frontotemporal lobar degeneration
Elisabeth Kapaki et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2008)
Normal pressure hydrocephalus: long-term outcome after shunt surgery
S. Pujari et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Guidelines from the guidelines committee of idiopathic normal pressure hydrocephalus, the Japanese society of normal pressure hydrocephalus
Masatsune Ishikawa et al.
NEUROLOGIA MEDICO-CHIRURGICA (2008)
CSF biomarkers in frontotemporal lobar degeneration with known pathology
H. Bian et al.
NEUROLOGY (2008)
The effect of cues on gait variability - Reducing the attentional cost of walking in people with Parkinson's disease
Katherine Baker et al.
PARKINSONISM & RELATED DISORDERS (2008)
Narrow CSF space at high convexity and high midline areas in idiopathic normal pressure hydrocephalus detected by axial and coronal MRI
Makoto Sasaki et al.
NEURORADIOLOGY (2008)
Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention
K. Iqbal et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCI
M. Ewers et al.
NEUROLOGY (2007)
The immediate effect of attentional, auditory, and a combined cue strategy on gait during single and dual tasks in Parkinson's disease
Katherine Baker et al.
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION (2007)
Comparative sequence analysis of leucine-rich repeats (LRRs) within vertebrate toll-like receptors
Norio Matsushima et al.
BMC GENOMICS (2007)
Expression of TGF-βs and TGF-β type II receptor in cerebrospinal fluid of patients with idiopathic normal pressure hydrocephalus
Xianfeng Li et al.
NEUROSCIENCE LETTERS (2007)
Cerebrospinal fluid tau, phospho-tau181 and β-amyloid1-42 in idiopathic normal pressure hydrocephalus:: a discrimination from Alzheimer's disease
E. N. Kapaki et al.
EUROPEAN JOURNAL OF NEUROLOGY (2007)
Analysis of potential diagnostic biomarkers in cerebrospinal fluid of idiopathic normal pressure hydrocephalus by proteomics
X. Li et al.
ACTA NEUROCHIRURGICA (2006)
Diagnosis, treatment, and analysis of long-term outcomes in idiopathic normal-pressure hydrocephalus
MJ McGirt et al.
NEUROSURGERY (2005)
Simultaneous measurement of β-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology
A Olsson et al.
CLINICAL CHEMISTRY (2005)
Clinical guidelines for idiopathic normal pressure hydrocephalus
M Ishikawa
NEUROLOGIA MEDICO-CHIRURGICA (2004)
Predictors of outcome in patients with normal-pressure hydrocephalus
U Meier et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2003)
Five-year outcome of normal pressure hydrocephalus with or without a shunt: Predictive value of the clinical signs, neuropsychological evaluation and infusion test
S Savolainen et al.
ACTA NEUROCHIRURGICA (2002)
Management of idiopathic normal-pressure hydrocephalus: a multiinstitutional study conducted in Japan
K Mori
JOURNAL OF NEUROSURGERY (2001)
The FAB - A frontal assessment battery at bedside
B Dubois et al.
NEUROLOGY (2000)
Tau protein is a potential biological marker for normal pressure hydrocephalus
T Kudo et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2000)
Share Paper
